Niels Hilmer Nielsen

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3.2K citations · Full text

Medicine, Oncology, Cancer Pharmacology +11

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Annemieke Cats, Edwin P. M. Jansen, Nicole C.T. van Grieken et al. · The Lancet Oncology · 2018 · 576 citations

Medicine, Oncology, Surgery +17

Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial

Gabriella Alexandersson von Döbeln, Fredrik Klevebro, A-B Jacobsen et al. · Diseases of the Esophagus · 2018 · 163 citations · Full text

Medicine, Oncology, Surgery +17

Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein

Niels Hilmer Nielsen, Stefan O. Emdin, Jenny Cajander et al. · Oncogene · 1997 · 150 citations

Life Sciences, Genetics, Molecular Biology +16

Tumor Specific VEGF-A and VEGFR2/KDR Protein are Co-expressed in Breast Cancer

Lisa Rydén, Barbro Linderholm, Niels Hilmer Nielsen et al. · Breast Cancer Research and Treatment · 2003 · 119 citations

Medicine, Molecular Biology, Oncology +11